The use of mechanical circulatory support devices in cardiovascular practice has risen
exponentially over the past decade. These devices are currently used for hemodynamic …

Thanks to advancements in percutaneous cardiac interventions, an expanding patient
population now qualifies for treatment through percutaneous endovascular procedures …

Background: Patients with severely reduced LV-EF≤ 30% undergoing CABG have a high
risk for postoperative cardiogenic shock. The optimal timing of an adequate hemodynamic …

Background: Impella is a percutaneous mechanical circulatory support device for treatment
of cardiogenic shock (CS) and high-risk percutaneous coronary interventions (HR-PCIs) …

Recently, there has been a growing interest in the concept of complex and high-risk
intervention in indicated patients (CHIP). In our previous studies, we defined the three CHIP …

In recent years, development of mechanical circulatory support devices has proved to be a
new treatment modality, in addition to standard pharmacological therapy, for patients with …

We present a case of cardiogenic shock secondary to refractory polymorphic ventricular
tachycardia associated with coronary ischemia resulting in cardiac arrest. Following the …

Advanced heart failure (AHF) presents a complex landscape with challenges spanning
diagnosis, management, and patient outcomes. In response, the integration of multimodality …

Aims Artificial intelligence (AI) has emerged as a potential useful tool to support clinical
treatment of heart failure, including the setting of mechanical circulatory support (MCS) …

Abstract Purpose of Review This review will focus on the indications of mechanical
circulatory support (MCS) for high-risk percutaneous coronary intervention (PCI) and then …